Monocyte-to-Lymphocyte Ratio (MLR) as a Possible Prognostic Marker of Latent Tuberculosis (LTBI) among Household Contacts of Active Tuberculosis (TB) PatientsTuberculosis (TB) is endemic in many developing countries including Pakistan. It is a leading cau

Author:

Khurshid Rukhshan,Sijjeel Farwa,Asim Samar,Mahmood Maira,Ashraf Huma,Rashid Shazia,Khan Muhammad YousafORCID,Abbas SafdarORCID,Nawaz Basharat,Naeem Mashal,Malik Noor Ul Ain

Abstract

Tuberculosis (TB) is endemic in many developing countries including Pakistan. It is a leading cause of death from a single infectious agent worldwide. Identification and early treatment of latent conditions help reduce the complications associated with TB. However, the identification of individuals with latent infection is a time taking and expensive process. According to previous studies, a promising and cheap biomarker of TB may be the monocyte-to-lymphocyte ratio (MLR). It may indicate a body’s immune response to Mycobacterium tuberculosis. Since household contacts of tuberculosis (TB) patients have an increased risk of latent tuberculosis (LTBI), using the established diagnostic procedures as well as checking their MLR might help determine if they contracted LTBI or not. We conducted across-sectional study to determine if MLR could be used to identify LTBI among household contacts of patients with active tuberculosis. Out of the 100 subjects selected for this study, about 40 patients were recently diagnosed with active tuberculosis, 40 were close contacts of these patients, while20 were chosen to be controls. The mean was 0.165, 0.06 (range 0.03–0.08), and 0.04 (0.02–0.04) inpatients with active tuberculosis, close contacts of patients, and control subjects, respectively. Hence, it was determined that MLR (> 0.6 %)is a significant predictor for LTBIand can be used to diagnose it in close contacts of TB patients. It was additionally observed that patients over the age of 50 with pulmonary tuberculosis have higher MLR.

Publisher

University of Management and Technology

Subject

General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3